Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.
Godier
Anne
A
Flaujac
Claire
C
Horellou
Marie-Hélène
MH
De Mesmay
Marine
M
Bécanne
Xavier
X
Parisot
Marion
M
Gauzit
Rémy
R
Samama
Charles-Marc
CM
D058186:Acute Kidney Injury / Q000150:complications / Q000628:therapy; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009767:Obesity, Morbid / Q000150:complications*; D010875:Pipecolic Acids / Q000627:therapeutic use*; D017582:Renal Replacement Therapy; D012128:Respiratory Distress Syndrome / Q000150:complications; D012772:Shock, Septic / Q000150:complications; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced*
D000925:Anticoagulants; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban